First Pharma IPR Decision Invalidates Patent Claims

, Corporate Counsel

   | 1 Comments

The U.S. Patent and Trademark Office's Patent Trial and Appeal Board issued what may be the first final written decision on an inter partes review in a pharma case.

What's being said

  • To the coder of the companies being mentioned: Merck & Co. is not the owner of Merck & Cie. Merck KGaA is the parent of Merck & Cie.

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202660839489

Thank you!

This article's comments will be reviewed.